Jump to content

User:Joerg Kurt Wegner

From Wikipedia, the free encyclopedia
19:02, Sunday, November 10, 2024 (UTC)
Welcome to Jörg Kurt Wegner's userpage

on Wikipedia, the free encyclopedia that anyone can edit

A molecule is not a vector, and ... never will be! JKW 15:03, 23 April 2006 (UTC)

Jörg Kurt Wegner - formal

JKW is not to be confused with the EAN13 barcode.
JKW is not to be confused with the EAN13 barcode.

About

To make it short. I am an identical twin, chemist and geek having a sound character. I am married.

Since 2005 I am working as senior scientist in antiinfective drug design being part of the in silico taskforce.

Joerg Kurt Wegner - visual

Extroverted 81%±10%, Sensing 60%±25%, Thinking 68%±10%, Judging 73%±10%

ESTJ ENTJ This user's MBTI types are ESTJ and ENTJ.
B
This user is a blogger at miningdrugs
B
This user is a blogger at joergkurtwegner
deDieser Benutzer spricht Deutsch als Muttersprache.
en-2This user can contribute with an intermediate level of English.
I believe combining modelling and mining will create new drugs.
Source codeThis user can solve problems with several languages.
This user is a recreational runner.
|
This user has been on Wikipedia for 19 years, 9 months and 3 days.

My work

I studied chemistry followed by my Ph.D. thesis in computer science (bioinformatics institute).

Since October 2005 I am working at Tibotec in Beerse (+ post-doc period). My work is now focused on drug development using molecular modelling and cheminformatics.

My actual drug targets are antiviral proteases and polymerases, e.g. for HIV.

I was the main developer of JOELib and one of the co-founders of a cheminformatics open source community called the 'blue obelisk' movement, because some of the administrators/developers met at the blue obelisk. It was founded 2005 at the ACS meeting in San Diego, where I had two talks. Since then I am still involved in chemistry related community work, e.g. as member of the ChemSpider advisory board. Fields that spark my interests are proteases, polymerases, drug design, antivirals, cheminformatics, chemogenomics, molecular modelling,QSAR, information theory and optimization algorithms.

More information

[[Category:1974 births|{{PAGENAME}}]]